New markers could identify patients most at risk of brain damage from CAR T cell immunotherapy – Cancer Research UK
Cancer Research UK |
New markers could identify patients most at risk of brain damage from CAR T cell immunotherapy
Cancer Research UK The team, from the Fred Hutchinson Cancer Research Centre, identified a number of potential biomarkers that could help doctors identify those most at risk of damage to the brain or nervous system (neurotoxicity) after CAR T cell therapy. "This type of … |
